SCHEMBL24869748

SCHEMBL24869748

Cn1cc2ncc(NC(=O)c3cc(F)c(-c4ccc(F)cc4Cl)cc3Cl)cc2n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 1/20 0.41
▸ MAOB P27338 1/20 0.41
▸ TP53 P04637 1/20 0.40
▸ THRB P10828 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ NR3C1 P04150 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ MAPT P10636 2/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ WDR5 P61964 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ CNR2 P34972 1/20 0.38
▸ TMPRSS4 Q9NRS4 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ RECQL P46063 1/20 0.37
▸ GRM4 Q14833 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24869753 0.83 MAOB (0.41) MAOAMAOBALDH1A1NR3C1KMT2A
SCHEMBL30875088 0.83 MAOB (0.41) MAOAMAOBALDH1A1NR3C1KMT2A
SCHEMBL24869349 0.81 TMPRSS4 (0.41) TP53NPC1RAB9AMAPTCNR2
SCHEMBL30875013 0.81 TMPRSS4 (0.41) TP53NPC1RAB9AMAPTCNR2
SCHEMBL24869751 0.80 MALT1 (0.40) NPC1RAB9AMAPTSMN1; SMN2WDR5
SCHEMBL24869345 0.80 IKBKE (0.41) ALDH1A1KMT2ATDP1WDR5
SCHEMBL24869743 0.79 MALT1 (0.44) MAOAMAOBALDH1A1NR3C1KMT2A
SCHEMBL24869355 0.78 NPC1 (0.49) TP53NPC1RAB9AMAPTSMN1; SMN2
SCHEMBL24869350 0.78 TP53 (0.40) TP53ALDH1A1KMT2ANPC1RAB9A
SCHEMBL24869351 0.78 KDM4E (0.42) ALDH1A1KMT2ATDP1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240336594-A1 SIX-MEMBERED ARYL OR HETEROARYL AMIDES, AND COMPOSITION AND USE THEREOF BETTA PHARMACEUTICALS CO., LTD (CN) 2024-10-10 — — US claimed
EP-4368618-A1 SIX-MEMBERED ARYL OR HETEROARYL AMIDES, AND COMPOSITION AND USE THEREOF Betta Pharmaceuticals Co., Ltd (CN) 2024-05-15 — — EP claimed
CN-117715898-A Six-membered aryl or heteroaryl amide compound, composition and application thereof 贝达药业股份有限公司 2024-03-15 — — CN claimed
US-20240336594-A1 SIX-MEMBERED ARYL OR HETEROARYL AMIDES, AND COMPOSITION AND USE THEREOF BETTA PHARMACEUTICALS CO., LTD (CN) 2024-10-10 — — US disclosed
EP-4368618-A1 SIX-MEMBERED ARYL OR HETEROARYL AMIDES, AND COMPOSITION AND USE THEREOF Betta Pharmaceuticals Co., Ltd (CN) 2024-05-15 — — EP disclosed
CN-117715898-A Six-membered aryl or heteroaryl amide compound, composition and application thereof 贝达药业股份有限公司 2024-03-15 — — CN disclosed
WO-2023279986-A1 SIX-MEMBERED ARYL OR HETEROARYL AMIDES, AND COMPOSITION AND USE THEREOF 贝达药业股份有限公司 2023-01-12 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240336594-A1 SIX-MEMBERED ARYL OR HETEROARYL AMIDES, AND COMPOSITION AND USE THEREOF MALT1, CYP51A1, BCR MAOA 1654/4885MAOB 2042/4885TP53 1339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback